Detailed Information on Publication Record
2023
Microbiome and pharmacotherapy in patients with gastrointestinal disorders
MLČŮCHOVÁ, Natálie and Petra BOŘILOVÁ LINHARTOVÁBasic information
Original name
Microbiome and pharmacotherapy in patients with gastrointestinal disorders
Authors
MLČŮCHOVÁ, Natálie (203 Czech Republic, belonging to the institution) and Petra BOŘILOVÁ LINHARTOVÁ (203 Czech Republic, guarantor)
Edition
RECETOX PhD Conference 2023, 2023
Other information
Language
English
Type of outcome
Konferenční abstrakt
Field of Study
30101 Human genetics
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
RIV identification code
RIV/00216224:14310/23:00134642
Organization unit
Faculty of Science
Keywords in English
microbiome;pharmacotherapy;gastrointestinal disorders
Změněno: 7/7/2023 10:53, Mgr. Terezie Slámová
Abstract
V originále
Background: Etiopathogenesis of gastrointestinal disorders (GDs), such as gastroesophageal reflux disease (GERD) and its complications, pancreatic cancer (PANC), and colorectal adenocarcinoma (CRC) is multifactorial; risk factors for disease development and/or progression include external factors, dysbiosis of host microbiota, genetic predisposition, and responsiveness to therapy. Objectives: The main aim of the dissertation project is to identify potential markers at the level of the host microbiome. Methods: Human and microbial DNA will be isolated from blood and biopsies from the digestive tract. Microbial DNA will be analyzed by 16S rRNA amplicon sequencing and quantified by multiplex qPCR method. Outcomes: Paired comparison of bacteriomes between healthy and pathological parts of the digestive tract will be performed to identify potentially risky host bacteriome profiles.
Links
NU20-03-00126, research and development project |
|